膜層析法市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、技術、最終用途、地區和競爭格局分類，2021-2031年）

全球膜層析法市場預計將從 2025 年的 3.9319 億美元成長到 2031 年的 8.7262 億美元，複合年成長率達到 14.21%。

這項技術利用配備特定配體的微孔膜，根據目標分子（例如蛋白質和抗體）的特定化學性質，選擇性地分離它們。該市場的成長主要受全球對生物製藥日益成長的需求以及為消除純化瓶頸而對高通量下游加工的需求所驅動。此外，這些膜技術無需清洗驗證，縮短了周轉時間，正在推動產業向一次性生產設施轉型，並加速其應用。歐洲製藥工業協會聯合會 (EFPIA) 的報告顯示，生物製造技術的進步帶來了顯著的規模經濟效益，預計到 2024 年，歐洲以研發為基礎的製藥業將在研發方面投入約 550 億歐元。

儘管存在這些成長要素，但由於薄膜的結合能力遠低於傳統層析法樹脂，市場仍面臨巨大的障礙。膜吸附劑在流通式純化步驟中表現出色，但其較低的表面積限制了其在大規模捕集應用中的有效性，而高結合能力對於成本效益至關重要。這項技術限制迫使製造商繼續使用傳統的填充床層析法法處理高濃度進料流，從而阻礙了樹脂基方法的完全替代，並減緩了膜層析法在所有純化步驟中的更廣泛應用。

市場促進因素

全球膜層析法市場的主要驅動力是病毒載體和基因治療藥物生產的擴張。與標準單株抗體不同，慢病毒和腺相關病毒（AAV）等病毒載體是大分子，在傳統的樹脂基介質中擴散緩慢，導致下游加工環節出現顯著瓶頸。膜吸附裝置利用對流解決了這個問題，即使對於這些大分子構建體也能保持高通量和高結合能力，有效滿足了產業可擴展的純化需求。如此活躍的研發管線催生了對這些專用技術的迫切需求。根據再生醫學聯盟2024年1月發布的《產業趨勢簡報》，美國和歐洲監管機構預計在2024年對多達17種新型細胞和基因療法做出核准決定，凸顯了推動該領域發展的商業性壓力。

同時，一次性生物製程技術的廣泛應用正在加速向膜分離解決方案的轉型。膜層析法裝置通常以一次性膠囊的形式製造，完美契合了諸如無需清潔驗證和防止多產品生產設施中的交叉污染等操作需求。這種相容性使製造商能夠最大限度地減少資本投資的相互依賴性和設施佔地面積，從而在競爭激烈的市場環境中獲得關鍵優勢。業界對一次性工具的依賴程度如此之高，以至於根據賽多利斯公司於2024年2月發布的2023年度報告，其生物程序解決方案部門（一次性技術的領導者）的銷售額達到了27億歐元。此外，默克集團在2024年報告稱，其生命科學部門在上年度的淨銷售額達到了93億歐元，凸顯了支持這些創新的供應鏈經濟效益。

市場挑戰

與傳統填料樹脂相比，膜吸附劑的低結合容量是限制全球膜層析法市場成長的一大阻礙因素。這項技術缺陷限制了薄膜在生物製藥生產回收階段的應用，而該階段需要高結合容量才能有效處理大量產品。在處理高濃度進料流時，薄膜會迅速飽和，導致製造商無法將其應用於大規模捕集工藝，其應用主要局限於流通式純化。因此，該技術無法成為商業生產中傳統方法的全面替代方案，其獲利潛力也僅限於某些下游製程。

鑑於越來越多的大分子藥物進入開發平臺，無法支持高效價捕獲尤其具有限制。根據美國藥品研究與製造商協會（PhRMA）預測，到2024年，全球將有超過8,000種藥物處於研發階段，其中許多是複雜的生物製藥，需要先進的下游加工流程。目前，膜技術無法經濟有效地滿足這些高需求治療藥物的大規模捕獲需求，因此生物製藥生產商仍然依賴樹脂柱。這種對傳統初級純化技術的依賴阻礙了膜層析法在生產流程中更廣泛的應用。

市場趨勢

製造商正加速將膜吸附裝置整合到連續下游生產線中，利用其在高流速下運作且不受填充床壓降限制的優勢。這種整合實現了穩態純化，顯著減少了設備面積和緩衝液消耗，同時提高了整體製程經濟性。大型合約研發生產企業（CDMO）不斷擴展其連續加工能力，展現出的商業性韌性，證明了這種轉變的有效性。例如，藥明生物在2024年8月發布的「2024會計年度中期財務業績」中報告稱，上半年新增了61個整合客戶計劃，這一成長勢頭得益於其自主研發的藥明UP連續加工平台的推出。

同時，市場正經歷數位轉型，新型系統融合了人工智慧和先進的感測器技術，用於最佳化層析法循環並預測膜堵塞。這些智慧工具能夠實現即時放行偵測和即時製程監控，確保產品品質穩定，同時最大限度地降低代價高昂的批次失敗風險。這種對數位化基礎設施的優先發展正在重塑整個產業的財務策略。正如羅克韋爾自動化公司在2024年8月發布的《智慧製造報告：生命科學》中所指出的，技術投資將飆升至營運預算的31%，目前96%的生命科學製造商正在使用或評估智慧製造技術以提高營運效率。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球膜層析法市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品（膠囊、盒式過濾器、濾芯、注射器過濾器、薄膜過濾器、濾板、離心柱等）
  • 依技術（離子交換膜層析法、親和性和膜層析法、疏水交互作用膜層析法）
  • 依最終用途（製藥/生技公司、CRO/CMO、學術研究機構）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美膜層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲膜層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區膜層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲膜層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10. 南美洲膜層析法市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球膜層析法市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• 3M Company
• Asahi Kasei Corporation
• Danaher Corporation
• Merck KGaA
• Cole-Parmer Instrument Company, LLC
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Air Products and Chemicals, Inc.
• Purilogics, LLC
• Restek Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Membrane Chromatography Market is projected to expand from USD 393.19 Million in 2025 to USD 872.62 Million by 2031, achieving a CAGR of 14.21%. This technology employs microporous membranes outfitted with specific ligands to selectively isolate target molecules, such as proteins and antibodies, based on their chemical characteristics. The market is primarily propelled by the escalating global demand for biopharmaceuticals and the necessity for high-throughput downstream processing to alleviate purification bottlenecks. Furthermore, the industry's transition toward single-use manufacturing facilities supports adoption, as these membranes negate cleaning validation requirements and speed up turnaround times. Highlighting the financial scale of these biomanufacturing advancements, the European Federation of Pharmaceutical Industries and Associations reported that the research-based pharmaceutical industry invested approximately €55,000 million in R&D across Europe in 2024.

Despite these growth drivers, the market encounters a substantial obstacle due to the limited binding capacity of membranes relative to traditional chromatography resins. Although membrane adsorbers perform exceptionally well in flow-through polishing phases, their reduced surface area restricts their effectiveness in large-scale capture applications where high binding capacity is crucial for cost efficiency. This technical constraint compels manufacturers to persist with traditional packed-bed chromatography for high-concentration feed streams, thereby preventing the total replacement of resin-based methods and slowing the wider expansion of membrane chromatography across all purification steps.

Market Driver

A major catalyst driving the Global Membrane Chromatography Market is the expansion of viral vector and gene therapy manufacturing. Unlike standard monoclonal antibodies, viral vectors like Lentivirus and AAV are large macromolecules that experience slow diffusion rates in traditional resin-based media, causing significant downstream processing bottlenecks. Membrane adsorbers resolve this by employing convective flow, which maintains high processing speeds and binding capacities even for these large structures, effectively meeting the industry's need for scalable purification. This intense pipeline activity is generating urgent demand for such specialized technologies; according to the Alliance for Regenerative Medicine's January 2024 "State of the Industry Briefing," regulatory bodies in the US and Europe were anticipated to issue decisions on up to 17 new cell and gene therapies in 2024, underscoring the commercial pressure fueling the sector.

concurrently, the widespread integration of single-use bioprocessing technologies is accelerating the transition toward membrane-based solutions. Membrane chromatography units are typically produced as disposable capsules, which aligns perfectly with operational needs to eliminate cleaning validation and prevent cross-contamination in multi-product facilities. This compatibility permits manufacturers to minimize capital interaction and facility footprint, a vital advantage in the competitive contract manufacturing landscape. The scale of industrial reliance on disposable tools is significant; according to Sartorius's "Annual Report 2023" published in February 2024, their Bioprocess Solutions division, a leader in single-use technologies, achieved €2.7 billion in sales revenue. Additionally, Merck KGaA reported in 2024 that its Life Science business sector generated €9.3 billion in net sales during the prior fiscal year, highlighting the economic magnitude of the supply chain supporting these advancements.

Market Challenge

The lower binding capacity of membrane adsorbers compared to conventional packed-bed resins represents a significant restraint on the global membrane chromatography market's growth. This technical deficiency limits the utility of membranes during the capture phase of biopharmaceutical manufacturing, where high binding capabilities are required to process large product volumes efficiently. Since membranes saturate rapidly when handling high-concentration feed streams, manufacturers are unable to employ them for large-scale capture steps, restricting their application primarily to flow-through polishing. Consequently, this prevents the technology from serving as a comprehensive substitute for traditional methods in commercial production and limits its revenue potential to specific downstream stages.

The inability to support high-titer capture is particularly restrictive given the increasing volume of large-molecule drugs entering the development pipeline. According to the Pharmaceutical Research and Manufacturers of America, there were over 8,000 medicines in development globally in 2024, many of which are complex biologics requiring intensive downstream processing. Because membranes cannot currently manage the bulk capture requirements for these high-demand therapies in a cost-effective manner, biomanufacturers continue to depend on resin-based columns. This reliance on legacy technology for primary purification prevents membrane chromatography from achieving broader adoption across the full manufacturing workflow.

Market Trends

Manufacturers are increasingly integrating membrane adsorbers into continuous downstream processing lines, utilizing their ability to operate at high flow rates without the pressure drop limitations associated with packed beds. This integration enables steady-state purification, which significantly lowers facility footprint and buffer consumption while enhancing overall process economics. The validity of this shift is demonstrated by the commercial resilience of major CDMOs expanding their continuous capabilities; for instance, WuXi Biologics reported in their "2024 Interim Results" in August 2024 that the company added 61 new integrated client projects in the first half of the year, a growth trajectory supported by the deployment of their proprietary WuXiUP continuous processing platform.

Simultaneously, the market is experiencing a digital transformation as new systems incorporate artificial intelligence and advanced sensor technologies to optimize chromatography cycles and predict membrane fouling. These intelligent tools facilitate real-time release testing and instantaneous process monitoring, ensuring consistent product quality while minimizing the risk of costly batch failures. The prioritization of such digital infrastructure is reshaping financial strategies throughout the sector. As noted by Rockwell Automation in the "State of Smart Manufacturing Report: Life Sciences Edition" from August 2024, technology investments have surged to account for 31% of operating budgets, with 96% of life sciences manufacturers now utilizing or evaluating smart manufacturing technologies to improve operational efficiency.

Key Market Players

• 3M Company
• Asahi Kasei Corporation
• Danaher Corporation
• Merck KGaA
• Cole-Parmer Instrument Company, LLC
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Air Products and Chemicals, Inc.
• Purilogics, LLC
• Restek Corporation

Report Scope

In this report, the Global Membrane Chromatography Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Membrane Chromatography Market, By Product

• Capsules Cassette & Cartridges
• Syringe Filters
• Membrane Filters
• Filter Plates
• Spin Columns
• and Others

Membrane Chromatography Market, By Technique

• Ion Exchange Membrane Chromatography
• Affinity Membrane Chromatography
• and Hydrophobic Interaction Membrane Chromatography

Membrane Chromatography Market, By End Use

• Pharmaceutical & Biotechnology Companies
• CRO & CMO
• and Academic Research Institutes

Membrane Chromatography Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Membrane Chromatography Market.

Available Customizations:

Global Membrane Chromatography Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Membrane Chromatography Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Capsules Cassette & Cartridges, Syringe Filters, Membrane Filters, Filter Plates, Spin Columns, and Others)
  • 5.2.2. By Technique (Ion Exchange Membrane Chromatography, Affinity Membrane Chromatography, and Hydrophobic Interaction Membrane Chromatography)
  • 5.2.3. By End Use (Pharmaceutical & Biotechnology Companies, CRO & CMO, and Academic Research Institutes)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Membrane Chromatography Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Membrane Chromatography Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Membrane Chromatography Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Membrane Chromatography Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By End Use

7. Europe Membrane Chromatography Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Membrane Chromatography Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Membrane Chromatography Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Membrane Chromatography Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Membrane Chromatography Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Membrane Chromatography Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By End Use

8. Asia Pacific Membrane Chromatography Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Membrane Chromatography Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Membrane Chromatography Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Membrane Chromatography Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Membrane Chromatography Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Membrane Chromatography Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Membrane Chromatography Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Membrane Chromatography Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Membrane Chromatography Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Membrane Chromatography Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By End Use

10. South America Membrane Chromatography Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Membrane Chromatography Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Membrane Chromatography Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Membrane Chromatography Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Membrane Chromatography Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. 3M Company
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Asahi Kasei Corporation
• 15.3. Danaher Corporation
• 15.4. Merck KGaA
• 15.5. Cole-Parmer Instrument Company, LLC
• 15.6. Thermo Fisher Scientific Inc.
• 15.7. Sartorius AG
• 15.8. Air Products and Chemicals, Inc.
• 15.9. Purilogics, LLC
• 15.10. Restek Corporation

16. Strategic Recommendations

17. About Us & Disclaimer